Showing results (1131-1140 of 1,172) with videos related to

Sort By:
Pageof 118
JAMA Neurology|July 11, 2022
Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization PriorityNicoline Schiess, Rodrigo Cataldi, Michael S Okun, et al.
American Journal of Hematology|December 10, 2019
Impact of MYD88L265P mutation status on histological transformation of Waldenström MacroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings|August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelinesStephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Human Vaccines & Immunotherapeutics|April 2, 2024
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide surveyPierre-André Jarrot, Adrien Mirouse, Sébastien Ottaviani, et al.
Science Translational Medicine|November 16, 2022
A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelaePeter M George, Anna Reed, Sujal R Desai, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Neurology|November 11, 2018
Neurologic phenotypes associated with COL4A1/2 mutations: Expanding the spectrum of diseaseSara Zagaglia, Christina Selch, Jelena Radic Nisevic, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Pageof 118